Surgical platform UltraGreen targets Asia for growth
Singapore is not being ruled out as a potential listing location as the company seeks to tap its largest market
[SINGAPORE] Medical procedures can be risky. One company is providing data that could help reduce complications from surgery.
Now, with Singapore in the centre of its plans, UltraGreen is looking to tap the sizeable Asian market for growth.
The company’s fluorescent dye and artificial intelligence (AI) platform gives surgeons an “inside look” into living tissue, by measuring and monitoring blood flow in the human tissue.
TRENDING NOW
Firm loses wrongful dismissal case despite following termination clause
Vietnam seeks US$76 billion a year from capital markets to ease reliance on banks
Soilbuild’s Lim Chap Huat sues Brookfield, claims it reneged on joint venture: WSJ
Citi, OCBC downgrade UOB post-Q2 results; RHB upgrades on valuation